|
1
|
WHO: Hepatitis B Fact sheet July 2019.
urihttp://www.who.int/mediacentre/factsheets/fs204/en/simplehttp://www.who.int/mediacentre/factsheets/fs204/en/.
|
|
2
|
WHO: Hepatitis C Fact sheet July 2019.
urihttp://www.who.int/mediacentre/factsheets/fs164/en/simplehttp://www.who.int/mediacentre/factsheets/fs164/en/.
|
|
3
|
WHO. Global Health Sector Strategies on
Viral Hepatitis, 2016-2021. urihttp://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1simplehttp://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_32-en.pdf?ua=1.
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Simonetti RG, Cammà C, Fiorello F, Cottone
M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A,
Giuseppetti R, et al: Hepatitis C virus infection as a risk factor
for hepatocellular carcinoma in patients with cirrhosis. A
case-control study. Ann Intern Med. 116:97–102. 1992.PubMed/NCBI View Article : Google Scholar
|
|
6
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Umemura T, Ichijo T, Yoshizawa K, Tanaka E
and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan.
J Gastroenterol. 44 (Suppl 19):102–107. 2009.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Omata M, Kanda T, Wei L, Yu ML, Chuang WL,
Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, et
al: APASL consensus statements and recommendations for hepatitis C
prevention, epidemiology, and laboratory testing. Hepatol Int.
10:681–701. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tanaka J, Akita T, Ohisa M, Sakamune K, Ko
K, Uchida S and Satake M: Trends in the total numbers of HBV and
HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 25:363–372.
2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tanaka J, Akita T, Ko K, Miura Y and
Satake M: Countermeasures against viral hepatitis B and C in Japan:
An epidemiological point of view. Hepatol Res. 49:990–1002.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Drafting Committee for Hepatitis
Management Guidelines, the Japan Society of Hepatology. Japan
Society of Hepatology guidelines for the management of hepatitis C
virus infection: 2019 update. Hepatol Res. 50:791–816.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Omata M, Nishiguchi S, Ueno Y, Mochizuki
H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, et al:
Sofosbuvir plus ribavirin in Japanese patients with chronic
genotype 2 HCV infection: An open-label, phase 3 trial. J Viral
Hepat. 21:762–768. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kumada H, Suzuki Y, Ikeda K, Toyota J,
Karino Y, Chayama K, Kawakami Y, Ido A, Yamamoto K, Takaguchi K, et
al: Daclatasvir plus asunaprevir for chronic HCV genotype 1b
infection. Hepatology. 59:2083–2091. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mizokami M, Yokosuka O, Takehara T,
Sakamoto N, Korenaga M, Mochizuki H, Nakane K, Enomoto H, Ikeda F,
Yanase M, et al: Ledipasvir and sofosbuvir fixed-dose combination
with and without ribavirin for 12 weeks in treatment-naive and
previously treated Japanese patients with genotype 1 hepatitis C:
An open-label, randomised, phase 3 trial. Lancet Infect Dis.
15:645–653. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chayama K, Suzuki F, Karino Y, Kawakami Y,
Sato K, Atarashi T, Naganuma A, Watanabe T, Eguchi Y, Yoshiji H, et
al: Efficacy and safety of glecaprevir/pibrentasvir in Japanese
patients with chronic genotype 1 hepatitis C virus infection with
and without cirrhosis. J Gastroenterol. 53:557–565. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Juanbeltz R, Pérez-García A, Aguinaga A,
Martínez-Baz I, Casado I, Burgui C, Goñi-Esarte S, Repáraz J,
Zozaya JM, San Miguel R, et al: Progress in the elimination of
hepatitis C virus infection: A population-based cohort study in
Spain. PLoS One. 13(e0208554)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Calvaruso V, Cabibbo G, Cacciola I, Petta
S, Madonia S, Bellia A, Tinè F, Distefano M, Licata A,
Giannitrapani L, et al: Incidence of hepatocellular carcinoma in
patients with HCV-associated cirrhosis treated with direct-acting
antiviral agents. Gastroenterology. 155:411–421.e4. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Carrat F, Fontaine H, Dorival C, Simony M,
Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki
JP, et al: Clinical outcomes in patients with chronic hepatitis C
after direct-acting antiviral treatment: A prospective cohort
study. Lancet. 393:1453–1464. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Razavi H, Sanchez Gonzalez Y, Yuen C and
Cornberg M: Global timing of hepatitis C virus elimination in
high-income countries. Liver Int. 40:522–529. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Aghemo A, Lampertico P and Colombo M:
Assessing long-term treatment efficacy in chronic hepatitis B and
C: Between evidence and common sense. J Hepatol. 57:1326–1335.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee
CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, et al:
Lamivudine for patients with chronic hepatitis B and advanced liver
disease. N Engl J Med. 351:1521–1531. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chang TT, Gish RG, de Man R, Gadano A,
Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, et al: A
comparison of entecavir and lamivudine for HBeAg-positive chronic
hepatitis B. N Engl J Med. 354:1001–1010. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu;
European Association for the Study of the Liver. EASL 2017 Clinical
Practice Guidelines on the management of hepatitis B virus
infection. J Hepatol. 67:370–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tanaka J: Ministry of Health, Labor and
Welfare 13th Council for Promotion of Measures against Hepatitis,
2015 (In Japanese) urihttps://http://www.mhlw.go.jp/stf/shingi2/0000075691.htmlsimplehttps://http://www.mhlw.go.jp/stf/shingi2/0000075691.html.
|
|
25
|
Tatsuoka S: Ministry of Health, Labor and
Welfare, Research project for practical application of medical
treatment in the field of diseases such as intractable diseases and
cancer (hepatitis-related research field) (In Japanese).
|
|
26
|
Nagao Y, Kawahigashi Y, Kimura K,
Nobayashi H and Sata M: Awareness survey of prejudice and
discrimination in hepatitis B and C virus-infected individuals. Adv
Res Gastroentero Hepatol. 7:6–11. 2017.
|
|
27
|
Ministry of Health, Labor and Welfare,
Study meeting for improving the quality of dentist 2017 (In
Japanese) urihttps://www.mhlw.go.jp/file/05-Shingikai-10801000-Iseikyoku-Soumuka/0000165542.pdfsimplehttps://http://www.mhlw.go.jp/file/05-Shingikai-10801000-Iseikyoku-Soumuka/0000165542.pdf.
|
|
28
|
Yatsuhashi H: Past, present, and future of
viral hepatitis C in Japan. Euroasian J Hepatogastroenterol.
6:49–51. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Toyoda H, Kumada T, Takaguchi K, Shimada N
and Tanaka J: Changes in hepatitis C virus genotype distribution in
Japan. Epidemiol Infect. 142:2624–2628. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kobayashi K: Questionnaire study of
needlestick injures and hepatitis B vaccination in general dental
practices. Japanese J Environmental Inf. 30:348–353. 2015.(In
Japanese).
|
|
31
|
Olubuyide IO, Ola SO, Aliyu B, Dosumu OO,
Arotiba JT, Olaleye OA, Odaibo GN, Odemuyiwa SO and Olawuyi F:
Hepatitis B and C in doctors and dentists in Nigeria. QJM.
90:417–422. 1997.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nagao Y, Matsuoka H, Kawaguchi T, Ide T
and Sata M: HBV and HCV infection in Japanese dental care workers.
Int J Mol Med. 21:791–799. 2008.PubMed/NCBI
|
|
33
|
Nagao Y, Ozaki T, Kawaguchi A, Chiba I,
Harada K, Saito T and Shiratsuchi S: Survey of dental health care
workers regarding their knowledge of viral liver disease and
prevention of its transmission, using an online questionnaire. Adv
Res Gastroentero Hepatol. 10:95–108. 2018.
|
|
34
|
Ali A, Khan S, Malik SM, Haris Iqbal M and
Aadil M: Comparison of knowledge and attitudes regarding hepatitis
B among healthcare professionals in Pakistan. Cureus.
9(e1049)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Garus-Pakowska A, Górajski M and Szatko F:
Knowledge and attitudes of dentists with respect to the risks of
blood-borne pathogens-A cross-sectional study in Poland. Int J
Environ Res Public Health. 14(69)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gambhir RS, Kumar M, Singh G, Singh A and
Kaur A: Hepatitis C: Knowledge and awareness of private dental
practitioners of a tricity in India. J Educ Health Promot.
7(7)2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rostamzadeh M, Afkhamzadeh A, Afrooz S,
Mohamadi K and Rasouli MA: Dentists' knowledge, attitudes and
practices regarding Hepatitis B and C and HIV/AIDS in Sanandaj,
Iran. BMC Oral Health. 18(220)2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Nagao Y, Kawaguchi T, Ide T and Sata M:
HCV or HBV infection self-disclosure to dentists. Kansenshogaku
Zasshi. 82:213–219. 2008.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
39
|
Medina JB, Andrade NS, de Paula Eduardo F,
Bezinelli L, Franco JB, Gallottini M, Braz-Silva PH and Ortega KL:
Bleeding during and after dental extractions in patients with liver
cirrhosis. Int J Oral Maxillofac Surg. 47:1543–1549.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Glassman P, Wong C and Gish R: A review of
liver transplantation for the dentist and guidelines for dental
management. Spec Care Dentist. 13:74–80. 1993.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Brigo S, Mancuso E and Pellicano R:
Dentistry and oral and maxillofacial surgery in the patient with
liver disease: Key messages for clinical practice. Minerva
Stomatol. 68:192–199. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Andreasen JO: Oral lichen planus. 1. A
clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol.
25:31–42. 1968.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pawlotsky JM, Ben Yahia M, Andre C, Voisin
MC, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani
ES, Duval J, et al: Immunological disorders in C virus chronic
active hepatitis: A prospective case-control study. Hepatology.
19:841–848. 1994.PubMed/NCBI
|
|
44
|
El-Serag HB, Hampel H, Yeh C and Rabeneck
L: Extrahepatic manifestations of hepatitis C among United States
male veterans. Hepatology. 36:1439–1445. 2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Negro F, Forton D, Craxì A, Sulkowski MS,
Feld JJ and Manns MP: Extrahepatic morbidity and mortality of
chronic hepatitis C. Gastroenterology. 149:1345–1360.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ferri C, Ramos-Casals M, Zignego AL,
Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC,
Sebastiani M, Casato M, et al: International diagnostic guidelines
for patients with HCV-related extrahepatic manifestations. A
multidisciplinary expert statement. Autoimmun Rev. 15:1145–1160.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cacoub P, Poynard T, Ghillani P, Charlotte
F, Olivi M, Piette JC and Opolon P: Extrahepatic manifestations of
chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Arthritis Rheum. 42:2204–2212. 1999.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cacoub P, Renou C, Rosenthal E, Cohen P,
Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P,
Musset L, et al: Extrahepatic manifestations associated with
hepatitis C virus infection. A prospective multicenter study of 321
patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine
Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.
Medicine (Baltimore). 79:47–56. 2000.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Stefanova-Petrova DV, Tzvetanska AH,
Naumova EJ, Mihailova AP, Hadjiev EA, Dikova RP, Vukov MI and
Tchernev KG: Chronic hepatitis C virus infection: Prevalence of
extrahepatic manifestations and association with cryoglobulinemia
in Bulgarian patients. World J Gastroenterol. 13:6518–6528.
2007.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Nagao Y, Sata M, Tanikawa K, Itoh K and
Kameyama T: Lichen planus and hepatitis C virus in the northern
Kyushu region of Japan. Eur J Clin Invest. 25:910–914.
1995.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Carrozzo M, Gandolfo S, Carbone M,
Colombatto P, Broccoletti R, Garzino-Demo P and Ghisetti V:
Hepatitis C virus infection in Italian patients with oral lichen
planus: A prospective case-control study. J Oral Pathol Med.
25:527–533. 1996.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Haddad J, Deny P, Munz-Gotheil C,
Ambrosini JC, Trinchet JC, Pateron D, Mal F, Callard P and
Beaugrand M: Lymphocytic sialadenitis of Sjögren's syndrome
associated with chronic hepatitis C virus liver disease. Lancet.
339:321–323. 1992.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Koike K, Moriya K, Ishibashi K,
Yotsuyanagi H, Shintani Y, Fujie H, Kurokawa K, Matsuura Y and
Miyamura T: Sialadenitis histologically resembling Sjögren syndrome
in mice transgenic for hepatitis C virus envelope genes. Proc Natl
Acad Sci USA. 94:233–236. 1997.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Nagao Y, Hanada S, Shishido S, Ide T,
Kumashiro R, Ueno T and Sata M: Incidence of Sjögren's syndrome in
Japanese patients with hepatitis C virus infection. J Gastroenterol
Hepatol. 18:258–266. 2003.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Nagao Y, Sata M, Tanikawa K, Itoh K and
Kameyama T: High prevalence of hepatitis C virus antibody and RNA
in patients with oral cancer. J Oral Pathol Med. 24:354–360.
1995.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mahale P, Sturgis EM, Tweardy DJ,
Ariza-Heredia EJ and Torres HA: Association between hepatitis C
virus and head and neck cancers. J Natl Cancer Inst.
108(djw035)2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Nagao Y and Sata M: Hepatitis C virus and
lichen planus. J Gastroenterol Hepatol. 19:1101–1113.
2004.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Carrozzo M: Oral diseases associated with
hepatitis C virus infection. Part 2: Lichen planus and other
diseases. Oral Dis. 14:217–228. 2008.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Shengyuan L, Songpo Y, Wen W, Wenjing T,
Haitao Z and Binyou W: Hepatitis C virus and lichen planus: A
reciprocal association determined by a meta-analysis. Arch
Dermatol. 145:1040–1047. 2009.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Lodi G, Pellicano R and Carrozzo M:
Hepatitis C virus infection and lichen planus: A systematic review
with meta-analysis. Oral Dis. 16:601–612. 2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Petti S, Rabiei M, De Luca M and Scully C:
The magnitude of the association between hepatitis C virus
infection and oral lichen planus: Meta-analysis and case control
study. Odontology. 99:168–178. 2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Alaizari NA, Al-Maweri SA, Al-Shamiri HM,
Tarakji B and Shugaa-Addin B: Hepatitis C virus infections in oral
lichen planus: A systematic review and meta-analysis. Aust Dent J.
61:282–287. 2016.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Gandolfo S, Richiardi L, Carrozzo M,
Broccoletti R, Carbone M, Pagano M, Vestita C, Rosso S and Merletti
F: Risk of oral squamous cell carcinoma in 402 patients with oral
lichen planus: A follow-up study in an Italian population. Oral
Oncol. 40:77–83. 2004.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Nagao Y, Sata M, Suzuki H, Kameyama T and
Ueno T: Histological improvement of oral lichen planus in patients
with chronic hepatitis C treated with interferon. Gastroenterology.
117:283–284. 1999.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Núñez M, Miralles ES, de las Heras ME and
Ledo A: Appearance of oral erosive lichen planus during interferon
alfa-2a therapy for chronic active hepatitis C. J Dermatol.
22:461–462. 1995.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Nagao Y, Sata M, Ide T, Suzuki H, Tanikawa
K, Itoh K and Kameyama T: Development and exacerbation of oral
lichen planus during and after interferon therapy for hepatitis C.
Eur J Clin Invest. 26:1171–1174. 1996.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Varela P, Areias J, Mota F, Canelhas A and
Sanches M: Oral lichen planus induced by interferon-alpha-N1 in a
patient with hepatitis C. Int J Dermatol. 39:239–240.
2000.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Areias J, Velho GC, Cerqueira R, Barbêdo
C, Amaral B, Sanches M, Massa A and Saraiva AM: Lichen planus and
chronic hepatitis C: Exacerbation of the lichen under
interferon-alpha-2a therapy. Eur J Gastroenterol Hepatol.
8:825–828. 1996.PubMed/NCBI
|
|
69
|
Nagao Y, Kawaguchi T, Ide T, Kumashiro R
and Sata M: Exacerbation of oral erosive lichen planus by
combination of interferon and ribavirin therapy for chronic
hepatitis C. Int J Mol Med. 15:237–241. 2005.PubMed/NCBI
|
|
70
|
Nagao Y, Kimura K, Kawahigashi Y and Sata
M: Successful treatment of hepatitis C virus-associated oral lichen
planus by interferon-free therapy with direct-acting antivirals.
Clin Transl Gastroenterol. 7(e179)2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Misaka K, Kishimoto T, Kawahigashi Y, Sata
M and Nagao Y: Use of direct-acting antivirals for the treatment of
hepatitis C virus-associated oral lichen planus: A case report.
Case Rep Gastroenterol. 10:617–622. 2016.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Nagao Y, Nakasone K, Maeshiro T, Nishida
N, Kimura K, Kawahigashi Y, Tanaka Y and Sata M: Successful
treatment of oral lichen planus with direct-acting antiviral agents
after liver transplantation for hepatitis C virus-associated
hepatocellular carcinoma. Case Rep Gastroenterol. 11:701–710.
2017.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Yoshikawa A, Terashita K, Morikawa K,
Matsuda S, Yamamura T, Sarashina K, Nakano S, Kobayashi Y, Sogabe
S, Takahashi K, et al: Interferon-free therapy with sofosbuvir plus
ribavirin for successful treatment of genotype 2 hepatitis C virus
with lichen planus: A case report. Clin J Gastroenterol.
10:270–273. 2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Nagao Y and Tsuji M: The discovery through
dentistry of potentially HCV-infected Japanese patients and
intervention with treatment. Adv Res Gastroentero Hepatol. 7:38–44.
2017.
|
|
75
|
Harada K, Nakashima D, Nagao Y, Hidaka I,
Sakaida I and Mishima K: Treatment of refractory oral lichen planus
using direct antiviral agents in a patient with chronic hepatitis
C: A case report. Oral Sci Int. 17:213–217. 2020.
|
|
76
|
Su TH, Tseng TC, Liu CJ, Chou SW, Liu CH,
Yang HC, Chen PJ, Chen DS, Chen CL and Kao JH: Antiviral therapy
against chronic hepatitis C is associated with a reduced risk of
oral cancer. Int J Cancer. 147:901–908. 2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Cacoub P, Desbois AC, Comarmond C and
Saadoun D: Impact of sustained virological response on the
extrahepatic manifestations of chronic hepatitis C: A
meta-analysis. Gut. 67:2025–2034. 2018.PubMed/NCBI View Article : Google Scholar
|
|
78
|
El-Serag HB, Christie IC, Puenpatom A,
Castillo D, Kanwal F and Kramer JR: The effects of sustained
virological response to direct-acting anti-viral therapy on the
risk of extrahepatic manifestations of hepatitis C infection.
Aliment Pharmacol Ther. 49:1442–1447. 2019.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Nagao Y, Kameyama T and Sata M: Hepatitis
C virus RNA detection in oral lichen planus tissue. Am J
Gastroenterol. 93(850)1998.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Nagao Y, Sata M, Noguchi S, Seno'o T,
Kinoshita M, Kameyama T and Ueno T: Detection of hepatitis C virus
RNA in oral lichen planus and oral cancer tissues. J Oral Pathol
Med. 29:259–266. 2000.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Arrieta JJ, Rodriguez-Inigo E, Casqueiro
M, Bartolomé J, Manzarbeitia F, Herrero M, Pardo M and Carreno V:
Detection of hepatitis C virus replication by In situ hybridization
in epithelial cells of anti-hepatitis C virus-positive patients
with and without oral lichen planus. Hepatology. 32:97–103.
2000.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Nagao Y, Sata M, Itoh K, Tanikawa K and
Kameyama T: Quantitative analysis of HCV RNA and genotype in
patients with chronic hepatitis C accompanied by oral lichen
planus. Eur J Clin Invest. 26:495–498. 1996.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Lodi G, Carrozzo M, Hallett R, D'Amico E,
Piattelli A, Teo CG, Gandolfo S, Carbone M and Porter SR: HCV
genotypes in Italian patients with HCV-related oral lichen planus.
J Oral Pathol Med. 26:381–384. 1997.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Sánchez-Pérez J, Moreno-Otero R, Borque
MJ, Rios-Buceta L and García-Díez A: Lichen planus and hepatitis C
virus infection: A clinical and virologic study. Acta Derm
Venereol. 78:305–306. 1998.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Nagao Y and Sata M: A retrospective
case-control study of hepatitis C virus infection and oral lichen
planus in Japan: Association study with mutations in the core and
NS5A region of hepatitis C virus. BMC Gastroenterol.
12(31)2012.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Nagao Y, Nishida N, Toyo-Oka L, Kawaguchi
A, Amoroso A, Carrozzo M, Sata M, Mizokami M, Tokunaga K and Tanaka
Y: Genome-wide association study identifies risk variants for
lichen planus in patients with hepatitis C virus infection. Clin
Gastroenterol Hepatol. 15:937–944.e5. 2017.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Kaishima T, Fujii T, Matsuoka T, Sakamune
K, Nagashima S, Yamamoto C, Chuon C, et al: Study of the issues of
receiving hepatitis screening and the rate of consulting
hospitals-The rate of recognized receiving hepatitis screening and
that of the unrecognized. Kanzo. 57:634–648. 2016.(In
Japanese).
|
|
88
|
Nagao Y, Sasaki T, Kuzuyama T, Takasato T,
Yoshikawa S, Konishi H, Oka K, Yamaguchi T, Konishi Y, Hanada H, et
al: Promotion by dentists of treatment of undiagnosed and untreated
HCV-infected patients. Adv Res Gastroentero Hepatol. 9:86–90.
2018.
|
|
89
|
Nagao Y, Nishioka S and Koresawa K:
Prevalence of viral liver disease and oral lichen planus in
patients who visited dental clinics: A study by the Ehime Dental
Association. OBM Hepatology Gastroenterology. 3:1–10. 2019.
|
